MedPath

四川梓橦宫药业股份有限公司

Ownership
-
Established
2005-04-26
Employees
-
Market Cap
-
Website
www.zitonggong.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字H20243240
Approval Date
Feb 23, 2024
NMPA

Vildagliptin Tablets

Product Name
维格列汀片
Approval Number
国药准字H20233639
Approval Date
Jun 7, 2023
NMPA

Celecoxib Capsules

Product Name
塞来昔布胶囊
Approval Number
国药准字H20233449
Approval Date
Apr 11, 2023
NMPA

东方胃药胶囊

Approval Number
国药准字Z20070001
Approval Date
Mar 21, 2022
NMPA

Pregabalin Oral Solution

Product Name
普瑞巴林口服溶液
Approval Number
国药准字H20223098
Approval Date
Mar 1, 2022
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H51022640
Approval Date
Apr 30, 2021
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H51021748
Approval Date
Apr 30, 2021
NMPA

Trimethoprim Tablets

Product Name
甲氧苄啶片
Approval Number
国药准字H51023132
Approval Date
Apr 30, 2021
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H51021747
Approval Date
Apr 30, 2021
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H51022537
Approval Date
Apr 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.